Product Information

DEPAKOTE DR 125 MG SPRINKLE CP is a brand product labeled by AbbVie Inc., priced at $1.9700 per EA under NDC 00074611413. Its NADAC has been published 657 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the Divalproex Sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DEPAKOTE DR 125 MG SPRINKLE CP

Divalproex Sodium
$1.9700per EA
High Outlier

Strength

125 mg/1

Manufacturer

AbbVie Inc.

NDC

00074611413

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

DIVALPROEX SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA019680

On Market Since

9/12/1989

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity
Mood Stabilizer

Price Statistics

The NADAC for DEPAKOTE DR 125 MG SPRINKLE CP has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 76.9%. The table below summarizes its recorded NADAC range and movement.

Current price$1.9700 per EA
All-time high$1.9719 (May 13, 2026)
All-time low$1.1134 (Nov 28, 2013)
52-week high$1.9719
52-week low$1.8780
Median price$1.6192
Average price$1.6039
Largest weekly change+9.9% (Jan 8, 2014)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+0.1%

3M

-0.1%

6M

+4.9%

1Y

+4.8%

3Y

+15.3%

5Y

+22.0%

All

+76.9%

Generic Alternatives

The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DEPAKOTE DR 125 MG SPRINKLE CP?

The current National Average Drug Acquisition Cost (NADAC) for DEPAKOTE DR 125 MG SPRINKLE CP, manufactured by AbbVie Inc., is $1.9700 per EA (NDC 00074611413), effective Jun 24, 2026.

How has the price of DEPAKOTE DR 125 MG SPRINKLE CP changed over time?

Over the history we have for it, the NADAC for DEPAKOTE DR 125 MG SPRINKLE CP has risen 76.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for DEPAKOTE DR 125 MG SPRINKLE CP?

Since Nov 28, 2013, the NADAC for DEPAKOTE DR 125 MG SPRINKLE CP has ranged from a low of $1.1134 (Nov 28, 2013) to a high of $1.9719 (May 13, 2026), with a median of $1.6192 per EA.

Are there cheaper alternatives to DEPAKOTE DR 125 MG SPRINKLE CP?

Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DIVALPROEX SOD DR 125 MG TAB, is $0.0541 per EA — about 97% below DEPAKOTE DR 125 MG SPRINKLE CP.

Who manufactures DEPAKOTE DR 125 MG SPRINKLE CP?

DEPAKOTE DR 125 MG SPRINKLE CP (NDC 00074611413) is labeled by AbbVie Inc., and CMS classifies it as a brand product.